To establish our tauopathy-relevant cell model, mouse neuroblastoma N2a cells were treated with okadaic acid (OA) (100 nM) to induce tau hyperphosphorylation and oligomerization for 6h and 24h (Fig 1A and 1B). The gene discussed is MAPT; the disease is neuroblastoma.